ArticleMicromachines2026
A Novel Continuous-Flow PCR Microdevice Operated by a Single Heat Source.
Article in Micromachines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This paper presents a constant-temperature, single-heat-source continuous-flow PCR (CF-PCR) microdevice that achieves stable thermal control for denaturation, annealing, and extension on a single platform. Key innovations include: (1) a metal-powder/PDMS thermal conduction block with trapezoidal geometry that generates a programmable temperature gradient and tunable residence times under one heat source; and (2) a thermoelectric cooler (TEC)-based Peltier system that creates distinct high- and low-temperature zones by co-optimizing the hot/cold side temperature difference, spacer material (92% alumina), and input voltage (3.6 V). A self-pressurized gas-diffusion micropump, enabled by a capillary quartz tube at the outlet, drives continuous sample flow without external actuation. The platform features three configurations: an on-chip zoned-heating design, an off-chip coiled-tube setup, and a battery-powered handheld system (727 g, 6 W, ~4 h runtime). Using CNC-machined and thermally bonded PMMA microchips with BSA passivation, the on-chip device achieves ~80% amplification efficiency relative to commercial instruments for H7N9 and pGEM-3Zf(+); the off-chip version reaches ~75%. The portable system yields HPV and RUBV amplification intensities comparable to benchtop devices. This approach provides a practical, scalable solution for "sample-in-answer-out" nucleic acid testing in point-of-care settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.